-
1
-
-
33748354488
-
Metabolic profiling of CSF: Evidence that early intervention may impact on disease progression and outcome in schizophrenia
-
E. Holmes, T.M. Tsang, and J.T. Huang et al. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia PLoS Med 3 8 2006 e327
-
(2006)
PLoS Med
, vol.3
, Issue.8
, pp. 327
-
-
Holmes, E.1
Tsang, T.M.2
Huang, J.T.3
-
2
-
-
84858705903
-
Pharmacotherapy challenges in patients with first-episode psychosis
-
A. Abdel-Baki, C. Ouellet-Plamondon, and A. Malla Pharmacotherapy challenges in patients with first-episode psychosis J Affect Disord 138 Suppl. 2012 S3 S14
-
(2012)
J Affect Disord
, vol.138 SUPPL.
-
-
Abdel-Baki, A.1
Ouellet-Plamondon, C.2
Malla, A.3
-
3
-
-
39949085594
-
World psychiatric association pharmacopsychiatry section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia
-
R. Tandon, R.H. Belmaker, and W.F. Gattaz et al. World psychiatric association pharmacopsychiatry section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia Schizophr Res 100 1-3 2008 20 38
-
(2008)
Schizophr Res
, vol.100
, Issue.13
, pp. 20-38
-
-
Tandon, R.1
Belmaker, R.H.2
Gattaz, W.F.3
-
4
-
-
0033850147
-
Depression in schizophrenia: Perspective in the era of "atypical" antipsychotic agents
-
S.G. Siris Depression in schizophrenia: perspective in the era of "atypical" antipsychotic agents Am J Psychiatry 157 9 2000 1379 1389
-
(2000)
Am J Psychiatry
, vol.157
, Issue.9
, pp. 1379-1389
-
-
Siris, S.G.1
-
5
-
-
0037177358
-
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
-
S. Jordan, V. Koprivica, and R. Chen et al. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor Eur J Pharmacol 441 3 2002 137 140
-
(2002)
Eur J Pharmacol
, vol.441
, Issue.3
, pp. 137-140
-
-
Jordan, S.1
Koprivica, V.2
Chen, R.3
-
6
-
-
6044224986
-
Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile
-
T. Hirose, Y. Uwahodo, and S. Yamada et al. Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile J Psychopharmacol 18 3 2004 375 383
-
(2004)
J Psychopharmacol
, vol.18
, Issue.3
, pp. 375-383
-
-
Hirose, T.1
Uwahodo, Y.2
Yamada, S.3
-
7
-
-
60349086480
-
A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia
-
S. Leucht, K. Komossa, and C. Rummel-Kluge et al. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia Am J Psychiatry 166 2 2009 152 163
-
(2009)
Am J Psychiatry
, vol.166
, Issue.2
, pp. 152-163
-
-
Leucht, S.1
Komossa, K.2
Rummel-Kluge, C.3
-
11
-
-
32644442073
-
Pharmacologie et mode d'action des neuroleptiques
-
N. Franck, and F. Thibaut Pharmacologie et mode d'action des neuroleptiques EMC - Psychiatrie 2 4 2005 282 299
-
(2005)
EMC - Psychiatrie
, vol.2
, Issue.4
, pp. 282-299
-
-
Franck, N.1
Thibaut, F.2
-
12
-
-
33644747716
-
Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study
-
A.F. Christensen, J. Poulsen, and C.T. Nielsen et al. Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study Acta Psychiatr Scand 113 2 2006 148 153
-
(2006)
Acta Psychiatr Scand
, vol.113
, Issue.2
, pp. 148-153
-
-
Christensen, A.F.1
Poulsen, J.2
Nielsen, C.T.3
-
13
-
-
84866487775
-
Effects of antipsychotic medications on quality of life and psychosocial functioning in patients with early-stage schizophrenia: 1-year follow-up naturalistic study
-
X. Guo, Z. Zhang, and J. Zhai et al. Effects of antipsychotic medications on quality of life and psychosocial functioning in patients with early-stage schizophrenia: 1-year follow-up naturalistic study Compr Psychiatry 53 7 2012 1006 1012
-
(2012)
Compr Psychiatry
, vol.53
, Issue.7
, pp. 1006-1012
-
-
Guo, X.1
Zhang, Z.2
Zhai, J.3
-
14
-
-
78651226362
-
Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder
-
P. Blier, and C. Blondeau Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder J Affect Disord 128 Suppl. 1 2011 S3 S10
-
(2011)
J Affect Disord
, vol.128
, Issue.SUPPL. 1
-
-
Blier, P.1
Blondeau, C.2
-
15
-
-
44849110854
-
Dosing atypical antipsychotics
-
A. Cutler, S. Ball, and S.M. Stahl Dosing atypical antipsychotics CNS Spectr 13 5 Suppl. 9 2008 1 16
-
(2008)
CNS Spectr
, vol.13
, Issue.5 SUPPL. 9
, pp. 1-16
-
-
Cutler, A.1
Ball, S.2
Stahl, S.M.3
-
16
-
-
25144456112
-
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
-
J.A. Lieberman, T.S. Stroup, and J.P. McEvoy et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N Engl J Med 353 12 2005 1209 1223
-
(2005)
N Engl J Med
, vol.353
, Issue.12
, pp. 1209-1223
-
-
Lieberman, J.A.1
Stroup, T.S.2
McEvoy, J.P.3
-
17
-
-
59049088231
-
Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia
-
B.J. Kinon, V.L. Stauffer, and S. Kollack-Walker et al. Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia J Clin Psychopharmacol 28 6 2008 601 607
-
(2008)
J Clin Psychopharmacol
, vol.28
, Issue.6
, pp. 601-607
-
-
Kinon, B.J.1
Stauffer, V.L.2
Kollack-Walker, S.3
-
18
-
-
33846852409
-
Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: A randomized, double-blind, placebo-controlled trial
-
T.K. Tran-Johnson, D.A. Sack, and R.N. Marcus et al. Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial J Clin Psychiatry 68 1 2007 111 119
-
(2007)
J Clin Psychiatry
, vol.68
, Issue.1
, pp. 111-119
-
-
Tran-Johnson, T.K.1
Sack, D.A.2
Marcus, R.N.3
-
19
-
-
33748659860
-
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: A double-blind, placebo-controlled comparison with intramuscular haloperidol
-
R. Andrezina, R.C. Josiassen, and R.N. Marcus et al. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol Psychopharmacology (Berl) 188 3 2006 281 292
-
(2006)
Psychopharmacology (Berl)
, vol.188
, Issue.3
, pp. 281-292
-
-
Andrezina, R.1
Josiassen, R.C.2
Marcus, R.N.3
-
20
-
-
84873660725
-
Aripiprazole versus olanzapine in the treatment of schizophrenia: A clinical study from india
-
K.C. Jindal, G.P. Singh, and V. Munjal Aripiprazole versus olanzapine in the treatment of schizophrenia: a clinical study from india Int J Psychiatry Clin Pract 17 1 2013 21 29
-
(2013)
Int J Psychiatry Clin Pract
, vol.17
, Issue.1
, pp. 21-29
-
-
Jindal, K.C.1
Singh, G.P.2
Munjal, V.3
-
21
-
-
55749106241
-
A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia
-
R.L. Findling, A. Robb, and M. Nyilas et al. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia Am J Psychiatry 165 11 2008 1432 1441
-
(2008)
Am J Psychiatry
, vol.165
, Issue.11
, pp. 1432-1441
-
-
Findling, R.L.1
Robb, A.2
Nyilas, M.3
-
22
-
-
33846860210
-
Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in chinese patients with risperidone as an active control: A randomized trial
-
H.Y. Chan, W.W. Lin, and S.K. Lin et al. Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in chinese patients with risperidone as an active control: a randomized trial J Clin Psychiatry 68 1 2007 29 36
-
(2007)
J Clin Psychiatry
, vol.68
, Issue.1
, pp. 29-36
-
-
Chan, H.Y.1
Lin, W.W.2
Lin, S.K.3
-
23
-
-
34547870543
-
A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia
-
J.P. McEvoy, D.G. Daniel, and W.H. Carson et al. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia J Psychiatr Res 41 11 2007 895 905
-
(2007)
J Psychiatr Res
, vol.41
, Issue.11
, pp. 895-905
-
-
McEvoy, J.P.1
Daniel, D.G.2
Carson, W.H.3
-
24
-
-
33749020011
-
The efficacy and safety of lower doses of aripiprazole for the treatment of patients with acute exacerbation of schizophrenia
-
[quiz: 719]
-
A.J. Cutler, R.N. Marcus, and S.A. Hardy et al. The efficacy and safety of lower doses of aripiprazole for the treatment of patients with acute exacerbation of schizophrenia CNS Spectr 11 9 2006 691 702 [quiz: 719]
-
(2006)
CNS Spectr
, vol.11
, Issue.9
, pp. 691-702
-
-
Cutler, A.J.1
Marcus, R.N.2
Hardy, S.A.3
-
25
-
-
0038488945
-
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder
-
S.G. Potkin, A.R. Saha, and M.J. Kujawa et al. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder Arch Gen Psychiatry 60 7 2003 681 690
-
(2003)
Arch Gen Psychiatry
, vol.60
, Issue.7
, pp. 681-690
-
-
Potkin, S.G.1
Saha, A.R.2
Kujawa, M.J.3
-
26
-
-
0036738786
-
Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
-
J.M. Kane, W.H. Carson, and A.R. Saha et al. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder J Clin Psychiatry 63 9 2002 763 771
-
(2002)
J Clin Psychiatry
, vol.63
, Issue.9
, pp. 763-771
-
-
Kane, J.M.1
Carson, W.H.2
Saha, A.R.3
-
27
-
-
84872535465
-
The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia
-
G. Sato, S. Yoshimura, and H. Yamashita et al. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia Hiroshima J Med Sci 61 4 2012 75 83
-
(2012)
Hiroshima J Med Sci
, vol.61
, Issue.4
, pp. 75-83
-
-
Sato, G.1
Yoshimura, S.2
Yamashita, H.3
-
28
-
-
65449123582
-
A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia
-
J.M. Kane, O. Osuntokun, and L.A. Kryzhanovskaya et al. A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia J Clin Psychiatry 70 4 2009 572 581
-
(2009)
J Clin Psychiatry
, vol.70
, Issue.4
, pp. 572-581
-
-
Kane, J.M.1
Osuntokun, O.2
Kryzhanovskaya, L.A.3
-
29
-
-
0141828595
-
Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: A placebo-controlled 26-week study
-
T.A. Pigott, W.H. Carson, and A.R. Saha et al. Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study J Clin Psychiatry 64 9 2003 1048 1056
-
(2003)
J Clin Psychiatry
, vol.64
, Issue.9
, pp. 1048-1056
-
-
Pigott, T.A.1
Carson, W.H.2
Saha, A.R.3
-
30
-
-
9144237416
-
Efficacy and safety of aripiprazole vs haloperidol for long-term maintenance treatment following acute relapse of schizophrenia
-
S. Kasper, M.N. Lerman, and R.D. McQuade et al. Efficacy and safety of aripiprazole vs haloperidol for long-term maintenance treatment following acute relapse of schizophrenia Int J Neuropsychopharmacol 6 4 2003 325 337
-
(2003)
Int J Neuropsychopharmacol
, vol.6
, Issue.4
, pp. 325-337
-
-
Kasper, S.1
Lerman, M.N.2
McQuade, R.D.3
-
31
-
-
60349130296
-
A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia
-
W.W. Fleischhacker, R.D. McQuade, and R.N. Marcus et al. A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia Biol Psychiatry 65 6 2009 510 517
-
(2009)
Biol Psychiatry
, vol.65
, Issue.6
, pp. 510-517
-
-
Fleischhacker, W.W.1
McQuade, R.D.2
Marcus, R.N.3
-
32
-
-
34249306913
-
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations
-
D.G. Daniel, G.W. Currier, and D.L. Zimbroff et al. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations J Psychiatr Pract 13 3 2007 170 177
-
(2007)
J Psychiatr Pract
, vol.13
, Issue.3
, pp. 170-177
-
-
Daniel, D.G.1
Currier, G.W.2
Zimbroff, D.L.3
-
33
-
-
33751247015
-
Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: Sub-analysis of a double-blind study
-
R. Andrezina, R.N. Marcus, and D.A. Oren et al. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study Curr Med Res Opin 22 11 2006 2209 2219
-
(2006)
Curr Med Res Opin
, vol.22
, Issue.11
, pp. 2209-2219
-
-
Andrezina, R.1
Marcus, R.N.2
Oren, D.A.3
-
34
-
-
34249729541
-
Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: A post-hoc analysis of 4 randomized, placebo-controlled clinical trials
-
S.R. Marder, B. West, and G.S. Lau et al. Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post-hoc analysis of 4 randomized, placebo-controlled clinical trials J Clin Psychiatry 68 5 2007 662 668
-
(2007)
J Clin Psychiatry
, vol.68
, Issue.5
, pp. 662-668
-
-
Marder, S.R.1
West, B.2
Lau, G.S.3
-
35
-
-
77249147515
-
Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: Post-hoc analysis of randomized clinical trial data
-
A.S. Robb, W.H. Carson, and M. Nyilas et al. Changes in positive and negative syndrome scale-derived hostility factor in adolescents with schizophrenia treated with aripiprazole: post-hoc analysis of randomized clinical trial data J Child Adolesc Psychopharmacol 20 1 2010 33 38
-
(2010)
J Child Adolesc Psychopharmacol
, vol.20
, Issue.1
, pp. 33-38
-
-
Robb, A.S.1
Carson, W.H.2
Nyilas, M.3
-
36
-
-
79955895316
-
Aripiprazole versus haloperidol treatment in early-stage schizophrenia
-
R.R. Girgis, D.B. Merrill, and S.R. Vorel et al. Aripiprazole versus haloperidol treatment in early-stage schizophrenia J Psychiatr Res 45 6 2011 756 762
-
(2011)
J Psychiatr Res
, vol.45
, Issue.6
, pp. 756-762
-
-
Girgis, R.R.1
Merrill, D.B.2
Vorel, S.R.3
-
37
-
-
77954142170
-
Effect of aripiprazole versus haloperidol on PANSS prosocial items in early-episode patients with schizophrenia
-
J.P. Docherty, R.A. Baker, and J. Eudicone et al. Effect of aripiprazole versus haloperidol on PANSS prosocial items in early-episode patients with schizophrenia Schizophr Res 120 1-3 2010 199 203
-
(2010)
Schizophr Res
, vol.120
, Issue.13
, pp. 199-203
-
-
Docherty, J.P.1
Baker, R.A.2
Eudicone, J.3
-
38
-
-
70149093748
-
Comparative utility of aripiprazole and haloperidol in schizophrenia: Post-hoc analysis of two 52-week, randomized, controlled trials
-
J.M. Kane, E. Kim, and H.J. Kan et al. Comparative utility of aripiprazole and haloperidol in schizophrenia: post-hoc analysis of two 52-week, randomized, controlled trials Appl Health Econ Health Policy 7 2 2009 109 119
-
(2009)
Appl Health Econ Health Policy
, vol.7
, Issue.2
, pp. 109-119
-
-
Kane, J.M.1
Kim, E.2
Kan, H.J.3
-
39
-
-
63349093738
-
Aripiprazole for patients with schizophrenia and schizoaffective disorder: An open-label, randomized, study versus haloperidol
-
I.R. de Oliveira, H. Elkis, and W.F. Gattaz et al. Aripiprazole for patients with schizophrenia and schizoaffective disorder: an open-label, randomized, study versus haloperidol CNS Spectr 14 2 2009 93 102
-
(2009)
CNS Spectr
, vol.14
, Issue.2
, pp. 93-102
-
-
De Oliveira, I.R.1
Elkis, H.2
Gattaz, W.F.3
-
40
-
-
34447117847
-
A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients schizophrenia trial of aripiprazole: (STAR) study
-
R. Kerwin, B. Millet, and E. Herman et al. A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients schizophrenia trial of aripiprazole: (STAR) study Eur Psychiatry 22 7 2007 433 443
-
(2007)
Eur Psychiatry
, vol.22
, Issue.7
, pp. 433-443
-
-
Kerwin, R.1
Millet, B.2
Herman, E.3
-
41
-
-
84873840061
-
Comparison of long-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: A trial using equipoise-stratified randomization
-
H. Jin, P.A. Shih, and S. Golshan et al. Comparison of long-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization J Clin Psychiatry 74 1 2013 10 18
-
(2013)
J Clin Psychiatry
, vol.74
, Issue.1
, pp. 10-18
-
-
Jin, H.1
Shih, P.A.2
Golshan, S.3
-
42
-
-
3242659711
-
Dose response and atypical antipsychotics in schizophrenia
-
B.J. Kinon, J. Ahl, and V.L. Stauffer et al. Dose response and atypical antipsychotics in schizophrenia CNS Drugs 18 9 2004 597 616
-
(2004)
CNS Drugs
, vol.18
, Issue.9
, pp. 597-616
-
-
Kinon, B.J.1
Ahl, J.2
Stauffer, V.L.3
-
43
-
-
84894490600
-
-
Aripiprazole: résumé des caractéristiques du produit
-
Aripiprazole: résumé des caractéristiques du produit, http://www.has-sante.fr/portail/jcms/c-400137/fr/abilify
-
-
-
-
44
-
-
77952974468
-
International consensus study of antipsychotic dosing
-
D.M. Gardner, A.L. Murphy, and H. O'Donnell et al. International consensus study of antipsychotic dosing Am J Psychiatry 167 6 2010 686 693
-
(2010)
Am J Psychiatry
, vol.167
, Issue.6
, pp. 686-693
-
-
Gardner, D.M.1
Murphy, A.L.2
O'Donnell, H.3
-
45
-
-
84864408922
-
World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
-
A. Hasan, P. Falkai, and T. Wobrock et al. World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance World J Biol Psychiatry 13 5 2012 318 378
-
(2012)
World J Biol Psychiatry
, vol.13
, Issue.5
, pp. 318-378
-
-
Hasan, A.1
Falkai, P.2
Wobrock, T.3
-
46
-
-
80755135527
-
Aripiprazole and dehydroaripiprazole plasma concentrations and clinical responses in patients with schizophrenia
-
S.K. Lin, C.K. Chen, and Y.L. Liu Aripiprazole and dehydroaripiprazole plasma concentrations and clinical responses in patients with schizophrenia J Clin Psychopharmacol 31 6 2011 758 762
-
(2011)
J Clin Psychopharmacol
, vol.31
, Issue.6
, pp. 758-762
-
-
Lin, S.K.1
Chen, C.K.2
Liu, Y.L.3
|